Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karine Chemin

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|August 12, 2023
Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domainsEveline Van Gompel, Deniz Demirdal, Catia Fernandes-Cerqueira, et al.
European Journal of Immunology|June 24, 2009
Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunityCapucine Picard, Stéphanie Dogniaux, Karine Chemin, et al.
RMD Open|November 18, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritisSara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, et al.
Journal of Autoimmunity|July 2, 2022
Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2Vaishnavi Srinivasan Iyer, Sanjaykumar V Boddul, Anna-Karin Johnsson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2015
A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid ArthritisKarine Chemin, Sabrina Pollastro, Eddie James, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart blockMargarita Ivanchenko, Gudny Ella Thorlacius, Malin Hedlund, et al.
Cancer Research|February 24, 2011
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancerBruno Salaun, Laurence Zitvogel, Carine Asselin-Paturel, et al.
BMC Immunology|May 20, 2020
Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritisChristina Gerstner, Sara Turcinov, Aase H Hensvold, et al.
EMBO Molecular Medicine|July 31, 2023
Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathiesAlexandra Argyriou, Begum Horuluoglu, Angeles Shunashy Galindo-Feria, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46Thierry Walzer, Mathieu Bléry, Julie Chaix, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|August 12, 2023
Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domainsEveline Van Gompel, Deniz Demirdal, Catia Fernandes-Cerqueira, et al.
European Journal of Immunology|June 24, 2009
Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunityCapucine Picard, Stéphanie Dogniaux, Karine Chemin, et al.
RMD Open|November 18, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritisSara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, et al.
Journal of Autoimmunity|July 2, 2022
Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2Vaishnavi Srinivasan Iyer, Sanjaykumar V Boddul, Anna-Karin Johnsson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2015
A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid ArthritisKarine Chemin, Sabrina Pollastro, Eddie James, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart blockMargarita Ivanchenko, Gudny Ella Thorlacius, Malin Hedlund, et al.
Cancer Research|February 24, 2011
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancerBruno Salaun, Laurence Zitvogel, Carine Asselin-Paturel, et al.
BMC Immunology|May 20, 2020
Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritisChristina Gerstner, Sara Turcinov, Aase H Hensvold, et al.
EMBO Molecular Medicine|July 31, 2023
Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathiesAlexandra Argyriou, Begum Horuluoglu, Angeles Shunashy Galindo-Feria, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46Thierry Walzer, Mathieu Bléry, Julie Chaix, et al.
Pageof 5